Luc Debruyne is president of global vaccines at GSK, a position he was appointed to in 2013. He joined GSK in 1991 and worked as a commercial strategy director in R&D, and since then has served in multiple capacities in many countries. Prior to his current role, he was appointed senior vice president of GSK Pharma Europe in 2012. Debruyne is a member of the IFPMA Vaccines CEO Roundtable and of the Belgian Federation of Enterprises’ management committee. He has previously co-chaired the EFPIA and has been a member of the board of Italy’s Farmindustria and its equivalent in The Netherlands, NEFARMA.
Previously
![Deep Dive: Preventing Pandemics](https://aspenideasfestival.imgix.net/null4b5541a1-5363-45cb-acbb-59fa1a51edc9/35465966606_015a3d00e7_h.jpg?auto=compress%2Cformat&fit=min&fm=jpg&h=225&q=80&rect=564%2C172%2C1012%2C569&w=400)
Infectious diseases represent one of the greatest threats to global health and security. The failures of the Ebola crisis demonstrated that we remain woefully unprepared, but...